Parulian Simanjuntak - Merck Tbk Independent Commissioner
| MERK Stock | IDR 4,010 10.00 0.25% |
Executive
Mr. Parulian Simanjuntak serves as Independent Commissioner of PT Merck Tbk since 2003. He is Chairman of the Audit Committee of the Company since May 2008. He obtained a degree in Business Administration from Cologne, Germany. His career started at Schering AG in Berlin, Germany. He then joined PT Schering Indonesia and served in several strategic positions, including as Finance and Administration Manager, Director of Finance, Vice President Director and finally as President Director . Currently, he dedicates himself to the International Pharmaceutical Manufacturers Group, an association of RDbased pharmaceutical companies operating in Indonesia, as its Executive Director. since 2003.
| Age | 73 |
| Tenure | 21 years |
| Phone | 62 21 2856 5600 |
| Web | https://www.merckgroup.com/id-id |
Merck Tbk Management Efficiency
The company has return on total asset (ROA) of 0.1573 % which means that it generated a profit of $0.1573 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2334 %, meaning that it generated $0.2334 on every $100 dollars invested by stockholders. Merck Tbk's management efficiency ratios could be used to measure how well Merck Tbk manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jan Hendra | Bank Central Asia | 43 | |
| Ike Andriani | Hanjaya Mandala Sampoerna | 45 | |
| Inge Setiawati | Bank Central Asia | 47 | |
| Vincentius Loho | Bank Rakyat Indonesia | 60 | |
| Adhyaksa Dault | Bank Rakyat Indonesia | 53 | |
| Ahmad Rahmany | Bank Rakyat Indonesia | 65 | |
| Sumantri Slamet | Bank Central Asia | 62 | |
| Liliana Tanaja | Mnc Land Tbk | 50 | |
| Ikhsan Rosan | Garuda Indonesia Persero | N/A | |
| Isa Rachmatarwata | Garuda Indonesia Persero | 50 | |
| Nicolaus Harjanto | Bank Rakyat Indonesia | 47 | |
| Bambang Tribaroto | Bank Rakyat Indonesia | N/A | |
| Herbert Siahaan | Garuda Indonesia Persero | N/A | |
| Fuad Rahmany | Bank Rakyat Indonesia | N/A | |
| Maharani Subandhi | Hanjaya Mandala Sampoerna | N/A | |
| Niken Rachmad | Hanjaya Mandala Sampoerna | 69 | |
| Dony Oskaria | Garuda Indonesia Persero | 47 | |
| Chairal Tanjung | Garuda Indonesia Persero | 50 | |
| Raden Pardede | Bank Central Asia | 58 | |
| Sonny Keraf | Bank Rakyat Indonesia | 60 | |
| Muzaffar Ismail | Garuda Indonesia Persero | 59 | |
Management Performance
| Return On Equity | 0.23 | |||
| Return On Asset | 0.16 |
Merck Tbk Leadership Team
Elected by the shareholders, the Merck Tbk's board of directors comprises two types of representatives: Merck Tbk inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merck. The board's role is to monitor Merck Tbk's management team and ensure that shareholders' interests are well served. Merck Tbk's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merck Tbk's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arryo Wachjuwidajat, Independent Director, Plant Director | ||
| Melisa Sandrianti, Corporate Secretary | ||
| Parulian Simanjuntak, Independent Commissioner | ||
| Aquira Moeladi, Human Head | ||
| Pachita Ramadhani, Head Mang | ||
| Bambang Nurcahyo, Finance Director | ||
| Rinita Daniati, Head Legal | ||
| Keong Hon, Commissioner | ||
| Mei Tang, President Commissioner | ||
| Eduan Tjong, Supply Mang | ||
| Atiek Sawitri, Corporate Secretary | ||
| Martin Feulner, President Director | ||
| Miranda Andamsari, Compliance Officer | ||
| Eza Evariza, Accounting Mang | ||
| Holger Guenzel, Director | ||
| Evie Yulin, Biopharma Director | ||
| Bradley Simpson, President Commissioner |
Merck Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Merck Tbk a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.23 | |||
| Return On Asset | 0.16 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.21 % | |||
| Current Valuation | 2.02 T | |||
| Shares Outstanding | 448 M | |||
| Shares Owned By Insiders | 86.65 % | |||
| Shares Owned By Institutions | 2.18 % | |||
| Price To Earning | 17.23 X | |||
| Price To Book | 2.91 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Tbk. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Merck Stock analysis
When running Merck Tbk's price analysis, check to measure Merck Tbk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck Tbk is operating at the current time. Most of Merck Tbk's value examination focuses on studying past and present price action to predict the probability of Merck Tbk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck Tbk's price. Additionally, you may evaluate how the addition of Merck Tbk to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |